Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03904446|
Recruitment Status : Recruiting
First Posted : April 5, 2019
Last Update Posted : September 26, 2019
Nicole M. Masse
Information provided by (Responsible Party):
Nicole M. Masse, University of Iowa
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||January 2021|
|Estimated Study Completion Date :||January 2021|
Şentürk Ş, Kağıtçı M, Balık G, Arslan H, Kır Şahin F. The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of Post-partum Haemorrhage. Basic Clin Pharmacol Toxicol. 2016 May;118(5):338-43. doi: 10.1111/bcpt.12500. Epub 2015 Nov 15.
Lavoie A, McCarthy RJ, Wong CA. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Anesth Analg. 2015 Jul;121(1):159-64. doi: 10.1213/ANE.0000000000000781.